Artal Group Sa Increased By $3.80 Million Its Medicines Co (Call) (MDCO) Position; Marshfield Associates Has Lowered By $2.23 Million Its Cummins (CMI) Stake

December 6, 2017 - By Richard Conner

Artal Group Sa increased Medicines Co (Call) (MDCO) stake by 100% reported in 2017Q2 SEC filing. Artal Group Sa acquired 100,000 shares as Medicines Co (Call) (MDCO)’s stock declined 20.30%. The Artal Group Sa holds 200,000 shares with $7.60 million value, up from 100,000 last quarter. Medicines Co (Call) now has $1.92 billion valuation. The stock decreased 1.48% or $0.4 during the last trading session, reaching $26.63. About 477,468 shares traded. The Medicines Company (NASDAQ:MDCO) has risen 16.70% since December 6, 2016 and is uptrending. It has by 0.00% the S&P500.

Marshfield Associates decreased Cummins Inc (CMI) stake by 2.34% reported in 2017Q2 SEC filing. Marshfield Associates sold 13,783 shares as Cummins Inc (CMI)’s stock rose 1.30%. The Marshfield Associates holds 575,579 shares with $93.37 million value, down from 589,362 last quarter. Cummins Inc now has $27.26B valuation. The stock decreased 0.35% or $0.57 during the last trading session, reaching $164.27. About 154,528 shares traded. Cummins Inc. (NYSE:CMI) has risen 43.32% since December 6, 2016 and is uptrending. It has outperformed by 26.62% the S&P500.

Analysts await Cummins Inc. (NYSE:CMI) to report earnings on February, 8. They expect $2.60 earnings per share, up 15.56% or $0.35 from last year’s $2.25 per share. CMI’s profit will be $431.52M for 15.80 P/E if the $2.60 EPS becomes a reality. After $2.71 actual earnings per share reported by Cummins Inc. for the previous quarter, Wall Street now forecasts -4.06% negative EPS growth.

Since June 19, 2017, it had 0 insider purchases, and 1 insider sale for $2.30 million activity. Ward Pat sold $2.30M worth of stock or 14,050 shares.

Among 27 analysts covering Cummins (NYSE:CMI), 6 have Buy rating, 3 Sell and 18 Hold. Therefore 22% are positive. Cummins had 88 analyst reports since July 22, 2015 according to SRatingsIntel. The stock of Cummins Inc. (NYSE:CMI) has “Hold” rating given on Thursday, December 17 by Deutsche Bank. The rating was downgraded by Robert W. Baird to “Underperform” on Thursday, April 21. As per Friday, December 1, the company rating was downgraded by Goldman Sachs. Barclays Capital maintained the stock with “Underweight” rating in Wednesday, October 12 report. Robert W. Baird maintained the stock with “Sell” rating in Tuesday, September 5 report. As per Tuesday, October 10, the company rating was maintained by RBC Capital Markets. The rating was maintained by Jefferies with “Hold” on Friday, June 30. On Wednesday, November 8 the stock rating was maintained by BMO Capital Markets with “Market Perform”. The firm has “Hold” rating by Piper Jaffray given on Monday, October 16. The firm has “Outperform” rating by CLSA given on Thursday, December 1.

Investors sentiment increased to 1.01 in Q2 2017. Its up 0.09, from 0.92 in 2017Q1. It is positive, as 49 investors sold CMI shares while 269 reduced holdings. 90 funds opened positions while 231 raised stakes. 130.61 million shares or 1.43% more from 128.77 million shares in 2017Q1 were reported. Old Republic Intl Corporation has 1.5% invested in Cummins Inc. (NYSE:CMI) for 284,000 shares. 132,200 were reported by Virginia Retirement Et Al. Amer Natl Registered Investment Advisor Inc has invested 0.3% in Cummins Inc. (NYSE:CMI). Credit Suisse Ag reported 335,414 shares or 0.05% of all its holdings. Da Davidson & holds 0.1% or 26,419 shares in its portfolio. Wells Fargo & Mn reported 0.06% of its portfolio in Cummins Inc. (NYSE:CMI). Moreover, Raymond James Svcs Advisors has 0.09% invested in Cummins Inc. (NYSE:CMI). 20,398 are owned by First Midwest Financial Bank Tru Division. Hodges Cap holds 0.02% or 1,895 shares in its portfolio. Cincinnati Insur holds 666,500 shares. Lenox Wealth Management Inc reported 281 shares. Oakworth reported 0.01% stake. North Amer holds 3,678 shares. 52,484 were reported by Sector Pension Investment Board. 2,420 are held by Mckinley Cap Management Limited Liability Company Delaware.

Artal Group Sa decreased Sarepta Therapeutics Inc (Call) (NASDAQ:SRPT) stake by 200,000 shares to 100,000 valued at $3.37M in 2017Q2. It also reduced Athene Hldg Ltd stake by 250,000 shares and now owns 200,000 shares. Global Blood Therapeutics In was reduced too.

Investors sentiment decreased to 1.22 in 2017 Q2. Its down 0.19, from 1.41 in 2017Q1. It dived, as 34 investors sold MDCO shares while 51 reduced holdings. 29 funds opened positions while 75 raised stakes. 86.33 million shares or 0.70% less from 86.94 million shares in 2017Q1 were reported. Neuberger Berman Lc, a New York-based fund reported 18,000 shares. Sector Pension Invest Board has invested 0.01% of its portfolio in The Medicines Company (NASDAQ:MDCO). Highvista Strategies Llc has invested 2.33% of its portfolio in The Medicines Company (NASDAQ:MDCO). The Louisiana-based Louisiana State Employees Retirement Systems has invested 0.05% in The Medicines Company (NASDAQ:MDCO). New York-based Atika Management Limited Liability Corp has invested 2.53% in The Medicines Company (NASDAQ:MDCO). Tci Wealth Advisors has 62 shares for 0% of their portfolio. Swiss Bancorp invested in 0.01% or 118,750 shares. Retirement Of Alabama owns 46,221 shares for 0.01% of their portfolio. Ameriprise Fincl invested in 418,573 shares. Putnam Investments Lc, Massachusetts-based fund reported 972,354 shares. Teachers Retirement System Of The State Of Kentucky owns 169,208 shares for 0.08% of their portfolio. Hall Laurie J Trustee accumulated 790 shares or 0% of the stock. Susquehanna Int Grp Limited Liability Partnership holds 0% of its portfolio in The Medicines Company (NASDAQ:MDCO) for 183,379 shares. Parametrica Mngmt Limited holds 7,063 shares. Arizona State Retirement accumulated 0.02% or 37,596 shares.

Among 10 analysts covering The Medicines Co (NASDAQ:MDCO), 9 have Buy rating, 0 Sell and 1 Hold. Therefore 90% are positive. The Medicines Co had 32 analyst reports since August 28, 2015 according to SRatingsIntel. The rating was initiated by Chardan Capital Markets on Wednesday, November 4 with “Buy”. On Wednesday, July 12 the stock rating was maintained by Oppenheimer with “Hold”. On Monday, August 31 the stock rating was maintained by Oppenheimer with “Market Perform”. The company was maintained on Tuesday, August 29 by Cowen & Co. The rating was maintained by H.C. Wainwright on Tuesday, July 25 with “Buy”. The firm earned “Buy” rating on Wednesday, November 29 by Oppenheimer. The company was maintained on Tuesday, November 8 by RBC Capital Markets. The firm has “Neutral” rating given on Monday, July 17 by Citigroup. As per Friday, August 28, the company rating was upgraded by Jefferies. RBC Capital Markets maintained the shares of MDCO in report on Monday, August 31 with “Outperform” rating.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our daily email newsletter.

Twitter Auto Publish Powered By :